CRH Investors Logo
NYSE
()
()
TSX
()
()

Board of Directors

CRH Medical Board of Directors

Composed of accomplished physicians and business leaders, our board of directors is focused on building a company with exceptional medical impact – and ongoing financial success.

Dr. Anthony F. Holler

Dr. Anthony F. Holler Chairman of the Board

Dr. Holler has been Chairman of the Board of Directors of CRH Medical since December 2005. He also serves as the CEO and Chairman of the Board of Directors for Sunniva Inc.
Prior to joining CRH, Dr. Holler was one of the founders of ID Biomedical Corporation since its inception in 1991. He held a number of executive positions with ID Biomedical, including Chief Executive Officer until the company was acquired by GlaxoSmithKline in December 2005 for $1.7 billion. Dr. Holler was also Chairman of Corriente Resources Inc., which sold for approximately $700 million to CRCC-Tongguan Investment Co. in 2010.

Before his involvement in public markets, Dr. Holler served as an emergency physician at University Hospital at the University of British Columbia. He holds a Bachelor of Science degree and a medical degree from the University of British Columbia and is a member of the British Columbia College of Physicians and Surgeons.

Dr. Holler is a member of the following Board Committees at CRH Medical: Audit Committee, Corporate Governance & Nominating Committee, and Compensation Committee.
David A. Johnson, MD, MACG, FASGE, FACP

David A. Johnson, MD, MACG, FASGE, FACP Director

Dr. Johnson has been an Independent Director of CRH Medical since June of 2010. Since 1989, he is also a partner of Gastrointestinal and Liver Specialists of Tidewater PLLC, in Norfolk, VA. In addition, Dr. Johnson currently serves as Professor of Medicine, Chief of Gastroenterology, in Eastern Virginia Medical School.

Dr. Johnson is Board-certified in Internal Medicine and Gastroenterology and is a past President of the American College of Gastroenterology, as well as a Master of the American College of Physicians. He has authored more than 600 papers in the field of gastroenterology.
Todd Patrick

Todd Patrick Director

Mr. Patrick has been an independent member of the Board of Directors of CRH Medical since May 2006. In addition, Mr. Patrick currently serves as President/ Chief Executive Officer and member of the Board of Directors of C3J Therapeutics Inc.

Before joining C3J Therapeutics, Mr. Patrick was the President and Board member of ID Biomedical Corporation from 1994 until 2006, when the company was acquired by GlaxoSmithKline. Prior to ID Biomedical, Mr. Patrick was the Director of the Office of Intellectual Property Administration at the University of California, Los Angeles (UCLA), where he was responsible for the patenting and licensing of intellectual property arising out of UCLA.

Mr. Patrick has been involved in several start-ups and has helped raise over $600 million in equity or debt capital. He has participated in several mergers and acquisitions, including the sale of ID Biomedical for $1.7 billion.

Mr. Patrick holds a B.A. (Economics) from the University of Washington and a Master’s in Business Administration from Washington State University.

Mr. Patrick is member of the following Board of Directors Committees at CRH Medical: Audit Committee, Corporate Governance & Nominating Committee, and Compensation Committee.

Mr. Patrick is Chair of the Audit Committee.
Ian Webb

Ian Webb Director

Mr. Webb has been an independent member of the Board of Directors of CRH Medical since May 2006.

Mr. Webb is a retired partner of the law firm of Borden Ladner Gervais LLP, (“BLG”), where he practiced in the areas of corporate and securities law, with an emphasis on the legal requirements of public companies. He retired from BLG in 2010. Prior to joining CRH, Mr. Webb was also a member of the Board of Directors of ID Biomedical Corp.

Mr. Webb was admitted to the British Columbia bar in 1982, after graduating from Osgoode Hall Law School at York University with a Bachelor of Laws in 1981. Prior to that, he received a Master of Science in Theoretical Physics from the University of Saskatchewan in 1976.

Mr. Webb is member of the following Board of Directors Committees at CRH Medical: Audit Committee, Corporate Governance & Nominating Committee, and Compensation Committee.

Mr. Webb is Chair of the Compensation Committee and the Governance and Nomination Committee.
Tushar Ramani, MD

Tushar Ramani, MD Chief Executive Officer, Director

Dr. Tushar Ramani brings over 30 years of experience in the anesthesia industry to CRH Medical Corporation. Prior to joining CRH, Dr. Ramani co-founded Anesthetix, a national provider of anesthesiology and pain management services offering anesthesia department clinical, operational, and financial evaluation, optimization and management. After Anesthetix was acquired by TeamHealth Holdings, Inc., a physician services organization listed on the NYSE at the time, Dr. Ramani remained as President of TeamHealth’s Anesthesia Division, growing it to over $300M in revenue. Dr. Ramani has co-developed several other anesthesia-related service companies in addition to Anesthetix, including a full-service healthcare staffing firm and an anesthesia revenue cycle management company.

More recently, Dr. Ramani worked with Summit Partners’ Healthcare & Life Sciences team as an Executive in Residence to identify growth investment opportunities in healthcare and evaluate prospects of existing investments. In connection with this appointment, he served as CEO of portfolio company, MedOptions, Inc., the nation's largest behavioral health services provider to post-acute care facilities.

Formerly a practicing anesthesiologist and interventional pain management specialist, Dr. Ramani attended Jefferson Medical College in Philadelphia, interned at Morristown Memorial Hospital, and completed residency in Anesthesiology and Interventional Pain Management at Mount Sinai Medical School, New York.